Form 4: ImageneBio Officer Granted Equity Awards

ImageneBio's Principal Accounting Officer, Erin Butler, was granted 22,500 Restricted Stock Units and 22,500 employee stock options.

Summary

• Erin Butler, Principal Accounting Officer of ImageneBio, Inc., received equity awards on December 30, 2025.
• The awards include 22,500 Restricted Stock Units (RSUs) and 22,500 employee stock options.
• Each RSU represents the contingent right to receive one share of ImageneBio's common stock upon settlement.
• The RSUs will vest 25% on July 15, 2026, March 1, 2027, March 1, 2028, and March 1, 2029, subject to continuous service.
• The employee stock options have an exercise price of $7.11 per share and are set to expire on December 30, 2035.
• The options will vest over four years, with 25% vesting on July 15, 2026, and the remaining shares vesting in 36 substantially equal monthly installments thereafter, also subject to continuous service.
• Following these transactions, Erin Butler beneficially owns 25,551 shares of common stock directly.

Sentiment

Score: 7

Explanation: The filing details standard executive compensation, which is generally a neutral to slightly positive event as it aligns management incentives with shareholder value and promotes retention. It does not, however, provide new operational or financial performance data that would significantly alter the company's outlook.

Positives

• The equity grants align the Principal Accounting Officer's financial interests with those of shareholders, promoting long-term value creation.
• The multi-year vesting schedules for both RSUs and stock options serve as a strong incentive for executive retention and sustained performance.

Negatives

• The future settlement of RSUs and exercise of stock options could lead to dilution for existing shareholders.

Risks

• Vesting of both the Restricted Stock Units and employee stock options is contingent upon Erin Butler's 'Continuous Service' as defined in the Issuer's 2025 Equity Incentive Plan. Failure to maintain continuous service would result in forfeiture of unvested awards.

Future Outlook

The grants establish a long-term incentive structure for the Principal Accounting Officer, with vesting schedules for RSUs extending through March 2029 and for options through monthly installments following July 2026, contingent on continuous service. This indicates a strategic focus on executive retention and performance alignment over several years.

Industry Context

This equity grant is a standard practice in many industries, particularly within publicly traded companies, to attract, retain, and motivate key executives. It aligns the executive's financial incentives with the long-term performance and growth objectives of the company, a common strategy to foster shareholder value.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential long-term benefits from aligned executive incentives; potential future dilution from the exercise and settlement of equity awards.
• Employees: Signals the company's commitment to executive retention and performance-based compensation, which may influence broader compensation strategies.

Next Steps

• Erin Butler must maintain 'Continuous Service' with ImageneBio, Inc. to ensure the vesting of the granted RSUs and stock options.
• ImageneBio, Inc. will recognize compensation expense related to these equity awards over their respective vesting periods in its financial statements.

Key Dates

Recommendation

This Form 4 filing reports routine equity compensation for a key executive. While it serves to align management's interests with shareholders and supports executive retention, it does not introduce new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in an investment recommendation. It is a standard disclosure for executive compensation.

Keywords

ImageneBio, IMA, SEC Filing, Form 4, Equity Grant, Restricted Stock Units, RSUs, Stock Options, Executive Compensation, Insider Transaction, Erin Butler